1Generation time in a discrete epidemic model with asymptomatic carriers: beyond geometric waiting times.2027 · Europe PMC
2Bacterial Membrane Vesicles as Versatile Platforms for Systemic and Mucosal Vaccines.2026 · Europe PMC
3Inflammation, infection, and immune dysregulation in chronic kidney disease: translational and epidemiological perspectives.2026 · Europe PMC
4Metabolomics analysis identifies differential metabolites and potential diagnostic biomarkers among pediatric sepsis subtypes.2026 · Europe PMC
5Enhancing data collection on socio-behavioral exposure pathways for emerging tickborne disease through engagement with surviving cases and their household members.2026 · Europe PMC
6Building a One Health mobile laboratory workforce: strengthening public health preparedness across Europe and Africa.2026 · Europe PMC
9Combination of Oral Doxycycline and Rifampin for Pan-Drug Resistant <i>Klebsiella pneumoniae</i> Infection: A Case Report.2026 · Europe PMC
10Complex pathogen interactions in upper respiratory tract infections in commercial free-range layers: A cross-sectional study.2026 · Europe PMC
11Haemophilus ducreyi Bacteria Causing Cutaneous Ulcer Outbreak in Children, Sierra Leone, December 2025.2026 · Europe PMC
12Beyond the Petri Dish: The Performance of a Multiplex PCR-Based Pneumonia Panel in Hospitalized Patients With Lower Respiratory Tract Infection.2026 · Europe PMC
13Screening and monitoring of travellers returning from countries affected by Bundibugyo virus: an overview of European approaches, July 2026.2026 · Europe PMC
14Tick-borne pathogens in a nature reserve area in the Netherlands: serological and molecular assessments in large herbivores and Ixodes ricinus ticks.2026 · Europe PMC
15Seasonal and Age-Specific Patterns of Viral and Bacterial Infections in Febrile Infants ≤ 90 Days Presenting to a Paediatric Emergency Department.2026 · Europe PMC
1616S rRNA Bacterial Identification in Evaluation of Orthopedic Infections and its Limited Role in Antimicrobial Stewardship.2026 · Europe PMC
17Bridging policy and practice: implementation of emerging infectious disease risk assessment in China from a One Health perspective.2026 · Europe PMC
18Global, regional, and national burden of bone and joint infections, 1990-2021: a comprehensive analysis of trends, pathogens, and antimicrobial resistance.2026 · Europe PMC
20From Suppurative Inflammation to Fibrotic Remodeling in Cutaneous Nocardiopsis Infection.2026 · Europe PMC
21Etiological surveillance of viral gastroenteritis in children aged less than 5 years in Tehran Province, Iran, 2023-2024.2026 · Europe PMC
22TRIM21 blocks DDX3X-driven stress granule formation during Mycobacterium tuberculosis infection via a non-canonical E3 ligase mechanism.2026 · Europe PMC
23Clinical characteristics and epidemiological analysis of 23 cases of tick-borne rickettsiosis in Xinjiang Uygur Autonomous Region.2026 · Europe PMC
24[Metagenomic sequencing-based pathogen analysis in pediatric severe acute non-A-E hepatitis].2026 · Europe PMC
25Comparison of growth, time series, and hybrid models for HIV infectious disease incidence in adults in Saudi Arabia.2026 · Europe PMC
26The impact of nonpharmaceutical interventions (NPIs) on rabies post-exposure prophylaxis: A comparative study in Wuhan, 2022 vs. 2023.2026 · Europe PMC
27Epidemiology of respiratory infectious diseases after the relaxation of COVID-19 policies: a retrospective study in Xiamen, China.2026 · Europe PMC
28Epidemiological characteristics of scarlet fever in Liaoning Province, China: a pre- and postpandemic comparison, 2005-2024.2026 · Europe PMC
29Microbe-induced migrasome-like structures and their role in microbial persistence, immune evasion and transmission.2026 · Europe PMC
31Case Report: Secondary syphilis with pulmonary involvement mimicking eosinophilic granulomatosis with polyangiitis - targeted next-generation sequencing as an adjunct in resolving an atypical non-exanthematous presentation.2026 · Europe PMC
32Structure-guided discovery and engineering of miniature CRISPR-Cas12m for epigenome editing.2026 · Europe PMC
33One Health Insights From Pteropus medius: Nipah Virus Spillover, Microbiota, and Antimicrobial Resistance.2026 · Europe PMC
34Rapid assessment of local disease control measures against the Marburg virus outbreak in Ethiopia in late 2025.2026 · Europe PMC
35Mycobacterium tuberculosis Rv3875 upregulates TRIM21 expression through the type I interferon/STAT1 pathway and promotes intracellular growth.2026 · Europe PMC
36Impact of Avibacterium paragallinarum infection on the upper respiratory tract microbiome of chickens2026 · Europe PMC
37Bordetella pertussis re-emergence - NGS-based RPTM analysis reveals the atypical clinical features of children.2026 · Europe PMC
38Respiratory Infection-Related Pathogens in the Pediatric Intensive Care Unit During 2019-2024 in Hubei, China.2026 · Europe PMC
40Human Infections Caused by Flavobacteriales: Clinical Characteristics and Antimicrobial Susceptibility Patterns.2026 · Europe PMC
42<i>Parahenipavirus langyaense</i> (Langya virus): Spillover ecology, noncanonical receptor-mediated entry, and future control strategies.2026 · Europe PMC
44Post-Sepsis Outcomes: Risk Factors for 90-Day Mortality and Infection Site-Pathogen Similarity in Recurrent Sepsis.2026 · Europe PMC
45A real-world implementation study of a TDM-guided dalbavancin model for bone and joint infections (101 Dalbatians).2026 · Europe PMC
46O-03 - A STRATEGY TO VISUALISE INFECTIOUS DISEASE NOTIFICATION DATA IN DYNAMIC CUSTOMISABLE DASHBOARDS FOR POLICYMAKERS, HEALTH PRACTITIONERS, ACADEMICS, THE MEDIA AND THE PUBLIC IN IRELAND2026 · Europe PMC
47Genomic Surveillance of Severe Acute Respiratory Syndrome Coronavirus 2 Variants in Airport and Port Wastewaters, Republic of Korea, 2025.2026 · Europe PMC
48Impact of hemo-alert program on appropriate antimicrobial therapy in hospitalized patients with bacteremia: a quasi-experimental study.2026 · Europe PMC
49[Current methods of systematic serological testing for infections in pregnant women in France].2026 · Europe PMC
50Hepatitis B virus proteome analysis identifies apolipoprotein C1 facilitating particle production and virus entry.2026 · Europe PMC
51The urgent need to integrate infectious diseases expertise into the management of cancer patients with infections in sub-Saharan Africa in the era of antimicrobial resistance: a policy brief.2026 · Europe PMC
52Epidemiology and factors associated with Talaromyces marneffei detection in the mainland of China, 2022-2024: a cross-sectional study of hospitalized patients.2026 · Europe PMC
53Narrative Review of the Pathophysiology of Post-Infectious Bronchiolitis Obliterans.2026 · Europe PMC
54Microbe on the move: <i>Akkermansia</i> in infectious diseases and emerging roles in gynecological health.2026 · Europe PMC
55Targeting virulence factors Psl and PcrV restores host defense in bronchiectasis and cystic fibrosis models.2026 · Europe PMC
56Comparison of unbiased metagenomic next generation sequencing to targeted multiplex diagnostic assays for the detection of respiratory viruses.2026 · Europe PMC
57Three Decades of Use of the Minimum Basic Data Set in Infectious Disease Research in Spain: A Scoping Review with an Evidence-Mapping Approach.2026 · Europe PMC
59Development and validation of GADA model for diagnosing hepatocellular carcinoma in Chinese hepatitis B patients.2026 · Europe PMC
60RACK1 in host immune response to infections: molecular mechanisms and therapeutic potentials.2026 · Europe PMC